Dr. David Walling, Principal Investigator and CEO of Collaborative Neuroscience Network, is interviewed on national radio about a new OCD trial CNS is conducting in partnership with Biohaven Pharmaceuticals. Listen to the full interview below.
To learn more about this study and others contact CNS today.
Leave A Comment